JUNO

Juno Therapeutics, Inc.
JUNO

Overview Fund Activity
Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

173 hedge funds and large institutions have $2.28B invested in Juno Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 52 increasing their positions, 50 reducing their positions, and 20 closing their positions.

Holders
173
Holders Change
+16
Holders Change %
+10.19%
% of All Funds
4.32%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
36
Increased
52
Reduced
50
Closed
20
Calls
$31.1M
Puts
$45.3M
Net Calls
-$14.2M
Net Calls Change
-$9.58M

Top Buyers

1
RG
1
Redmile Group
California
$66.3M
2
O
2
OrbiMed
New York
$27.4M
3
Jennison Associates
3
Jennison Associates
New York
$22.7M
4
WA
4
Wasatch Advisors
Utah
$19.8M
5
Morgan Stanley
5
Morgan Stanley
New York
$43.3M

Top Sellers

1
HM
1
HealthCor Management
New York
$0
2
BCM
2
Biomark Capital Management
Connecticut
$55.7M
3
Norges Bank
3
Norges Bank
Norway
$39.7M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.39M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$53.4M
Name Market Value Shares Shares
Change 		Shares
Change %
CM
1
Crestline Management
Texas
$520M 17,382,192 +33,393 +0.2%
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$334M 11,173,129 -24,734 -0.2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$188M 6,285,676 +131,864 +2%
BlackRock
4
BlackRock
New York
$128M 4,294,296 +110,503 +3%
State Street
5
State Street
Massachusetts
$96.7M 3,236,384 +222,754 +7%
Capital World Investors
6
Capital World Investors
California
$72.5M 2,425,000 +295,000 +14%
RG
7
Redmile Group
California
$66.3M 2,219,616 +2,219,616 New
BB
8
BB Biotech
Switzerland
$65.3M 2,185,000 – –
BCM
9
Biomark Capital Management
Connecticut
$55.7M 1,864,174 -304,427 -14%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$53.4M 1,786,938 -131,654 -7%
ACH
11
ArrowMark Colorado Holdings
Colorado
$48.5M 1,622,380 +94,674 +6%
Morgan Stanley
12
Morgan Stanley
New York
$43.3M 1,448,652 +588,604 +68%
Norges Bank
13
Norges Bank
Norway
$39.7M 1,327,073 -251,769 -16%
First Trust Advisors
14
First Trust Advisors
Illinois
$39.2M 1,309,967 -67,700 -5%
OFM
15
Omega Fund Management
Massachusetts
$36.8M 1,229,512 – –
Temasek Holdings
16
Temasek Holdings
Singapore
$27.4M 915,750 – –
O
17
OrbiMed
New York
$27.4M 915,208 +915,208 New
Mitsubishi UFJ Trust & Banking
18
Mitsubishi UFJ Trust & Banking
Japan
$27M 901,750 -22,900 -2%
Goldman Sachs
19
Goldman Sachs
New York
$25.9M 867,381 +7,521 +0.9%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$22.7M 760,222 -8,490 -1%
Jennison Associates
21
Jennison Associates
New York
$22.7M 759,086 +759,086 New
CAM
22
Cormorant Asset Management
Massachusetts
$22.4M 750,000 +100,000 +15%
WA
23
Wasatch Advisors
Utah
$19.8M 661,998 +661,998 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$19.7M 658,427 +63,291 +11%
AIM
25
ARK Investment Management
Florida
$15M 500,296 +252,029 +102%
1
2 3 4 5